Clinicopathological characteristics and prognostic value of the cancer stem cell marker ALDH1 in ovarian cancer: a meta-analysis

References

• SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
   PubMed Web of Science ®Google Scholar
• KippsETanDSKayeSBMeeting the challenge of ascites in ovarian cancer: new avenues for therapy and researchNat Rev Cancer201313427328223426401
   PubMed Web of Science ®Google Scholar
• RahmanMDeleyrolleLVedam-MaiVAzariHAbd-El-BarrMReynoldsBAThe cancer stem cell hypothesis: failures and pitfallsNeurosurgery201168253154521135745
   PubMed Web of Science ®Google Scholar
• AntoniouAHebrantADomGDumontJEMaenhautCCancer stem cells, a fuzzy evolving concept: a cell population or a cell property?Cell Cycle201312243743374824270846
   PubMed Web of Science ®Google Scholar
• HuangRLiXHolmRTropeCGNeslandJMSuoZThe expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: a retrospective studyBMC Cancer201515150226148881
   PubMed Web of Science ®Google Scholar
• ZhouCSunBThe prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysisOral Oncol201450121144114825264224
   PubMed Web of Science ®Google Scholar
• ChuteJPMuramotoGGWhitesidesJInhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cellProc Natl Acad Sci U S A200610331117071171216857736
   PubMed Web of Science ®Google Scholar
• KurodaTHirohashiYTorigoeTALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosisPLoS One201386e6515823762304
   PubMed Web of Science ®Google Scholar
• YuLZhuBWuSEvaluation of the correlation of vasculogenic mimicry, ALDH1, KiSS-1, and MACC1 in the prediction of metastasis and prognosis in ovarian carcinomaDiagn Pathol20171212328253891
   PubMed Web of Science ®Google Scholar
• StangACritical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEur J Epidemiol201025960360520652370
   PubMed Web of Science ®Google Scholar
• ZhouZRZhangTSLiBMaoZZengXTLiuSXExtracting and transforming of appropriate data of meta-analysis in survival curveChin J Evid Based Cardiovasc Med20146243247
   Google Scholar
• JingHLiuXYChenYLBaiLPZhengAExpression level of membrane-associated proteins numb in epithelial ovarian carcinoma and its relationship with ovarian cancer stem cell markers CD117, CD133, ALDH1J Sichuan Univ2016476878882
   Google Scholar
• XueQMJiXQWangHYExpressions of ALDH1 and Nanog proteins in ovarian cancer and their clinical significanceChin J Clin Res2015288992995
   Google Scholar
• YuLSongWQZhouLWuSWWangDNCorrelation between expression of ALDH1/ABCG2 and microvessel formation in epithelial ovarian cancerChin J Pathophysiol2016321018071814
   Google Scholar
• KimMJKimARJeongJYCorrelation of ALDH1 and Notch3 expression: clinical implication in ovarian carcinomasJ Cancer20178163331334229158806
   PubMed Web of Science ®Google Scholar
• SunYJiaXWuXHigh expressions of Lgr5 and ALDH1 in primary epithelial ovarian cancer correlate with advanced tumor stage and grade as well as poor prognosis of the patientsGynecol Obstet Invest Epub2015620
   Web of Science ®Google Scholar
• LandenCNGoodmanBWNickAMMarkers for discovering stemness in ovarian cancerGynecol Oncol20091122S140S141
   Web of Science ®Google Scholar
• MizunoTSuzukiNMakinoHCancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen speciesGynecol Oncol2015137229930525541259
   PubMed Web of Science ®Google Scholar
• RuscitoICacsire Castillo-TongDVergoteIExploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the ovarian cancer therapy-innovative models prolong survival (OCTIPS) consortiumEur J Cancer20177921422528525846
   PubMed Web of Science ®Google Scholar
• ChenPXLiQYYangZMusashi-1 expression is a prognostic factor in ovarian adenocarcinoma and correlates with ALDH-1 expressionPathol Oncol Res20152141133114025971681
   PubMed Web of Science ®Google Scholar
• DengSYangXLassusHDistinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancersPLoS One201054e1027720422001
   PubMed Web of Science ®Google Scholar
• LiebscherCAPrinzlerJSinnBVAldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinomaHum Pathol20134481465147123465277
   PubMed Web of Science ®Google Scholar
• WangYCYoYTLeeHYALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcomeAm J Pathol201218031159116922222226
   PubMed Web of Science ®Google Scholar
• AyubTHKeyver-PaikMDDebaldMAccumulation of ALDH1-positive cells after neoadjuvant chemotherapy predicts treatment resistance and prognosticates poor outcome in ovarian cancerOncotarget2015618164371644825999351
   PubMed Web of Science ®Google Scholar
• ChangBLiuGXueFALDH1 expression correlates with favorable prognosis in ovarian cancersMod Pathol200922681782319329942
   PubMed Web of Science ®Google Scholar
• ParkYTJeongJYLeeMJMicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistanceJ Ovarian Res2013611823522567
   PubMed Web of Science ®Google Scholar
• WuDWangJCaiYEffect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccineJ Ovarian Res201586826497895
   PubMed Web of Science ®Google Scholar
• GinestierCHurMHCharafe-JauffretEALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcomeCell Stem Cell20071555556718371393
   PubMed Web of Science ®Google Scholar
• WuXHZhaoTTCaoQYEffect of low-dose metronomic chemotherapy on ALDH1 expression in human ovarian carcinoma xenograft tumor in nude miceTumor2015354377383
   Google Scholar
• YasudaKThe significance of stress-responsive molecules in cancer stem cells derived from ovarian and endometrial cancerCancer Res2012728
   Google Scholar
• KakarSSWorthCAWangZCarterKRatajczakMGunjalPDOXIL when combined with Withaferin A (WFA) targets ALDH1 positive cancer stem cells in ovarian cancer. EMBO Mol MedEpub20164194
   Google Scholar
• MaYMZhaoSPrognostic values of aldehyde dehydrogenase I isoenzymes in ovarian cancerOnco Targets Ther201691981198827110126
   PubMed Web of Science ®Google Scholar